Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 4
Submit an article Journal homepage
449
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma

David Yashara Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA;b Harbor-UCLA Medical Center, Carson, CA, USAView further author information
,
Tanya M. Spektorc Oncotherapeutics, West Hollywood, CA, USAView further author information
,
Daisy Martinezc Oncotherapeutics, West Hollywood, CA, USAView further author information
,
Matthew Ghermezic Oncotherapeutics, West Hollywood, CA, USAView further author information
,
Regina A. Swiftd James R. Berenson, MD, Inc., West Hollywood, CA, USAView further author information
,
Benjamin Eadesd James R. Berenson, MD, Inc., West Hollywood, CA, USAView further author information
,
Gary Schwartzd James R. Berenson, MD, Inc., West Hollywood, CA, USAView further author information
,
Shahrooz Eshaghiane Compassionate Oncology Medical Group, Los Angeles, CA, USAView further author information
,
Stephen Limf Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, USAView further author information
,
Robert Vesciof Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, USAView further author information
&
James R. Berensona Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA;c Oncotherapeutics, West Hollywood, CA, USA;d James R. Berenson, MD, Inc., West Hollywood, CA, USACorrespondence[email protected]
View further author information
 show all
Pages 975-983 | Received 07 Jul 2021, Accepted 03 Nov 2021, Published online: 24 Nov 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antonella Bruzzese, Enrica Antonia Martino, Ernesto Vigna, Enrico Iaccino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Gianfranco Filippelli, Antonino Neri, Fortunato Morabito & Massimo Gentile. (2023) Elotuzumab in multiple myeloma. Expert Opinion on Biological Therapy 23:1, pages 7-10.
Read now

Articles from other publishers (2)

Ivan Cancarevic, Usman Ilyas & Mahmoud Nassar. (2023) Hypophosphatemia in Patients With Multiple Myeloma. Cureus.
Crossref
Melania Grottoli, Paolo Carrega, Lodovica Zullo, Chiara Dellepiane, Giovanni Rossi, Francesca Parisi, Giulia Barletta, Linda Zinoli, Simona Coco, Angela Alama, Silvia Marconi, Monica Parodi, Paola Orecchia, Sara Bassi, Massimo Vitale, Maria Cristina Mingari, Ulrich Pfeffer, Carlo Genova & Gabriella Pietra. (2022) Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers 14:20, pages 5046.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.